Cancer Therapy : Differentiation, Immunomodulation and Angiogenesis (NATO Asi Series (Closed) / NATO Asi Subseries H: (Closed)) (Reprint)

595.92 MYR
Member Price
536.33
English

Product Description

§06§ §16§Provided here is a comprehensive examination of the basicand clinical condition of three innovative and promisingapproaches to cancer therapy, which may support or evensubstitute chemotherapy: differentiation, immunomodulation,and inhibition of angiogenesis.Differentiation shouldnormalize neoplastic cells and makethem compatible with the host. Its feasibility withretinoids, interferons, chemotherapeutic and other agents isdiscussed. Modulation by biological agents, cytotoxiceffector cells and drugs is considered in attempts toboost endogenous antitumour defenses and/or to renderneoplastic cells more susceptible to the immune attack ofthe host. Finally, the important aspect of interfering withtumour blood vessel development and function is takeninto account.Consideringthe importance that chemotherapy has in cancertreatment and in view of a more and more integratedstrategy, the relationship between the aforementionedapproaches and chemotherap §16§eutic agents and chemoresistanceis treated in detail.

Available to Order

Usually dispatches within 3-4 weeks

While every attempt has been made to ensure stock availability, occasionally we may run out of stock at our stores.

Free shipping for Peninsula on orders over 120.00MYR

Discount is applied at checkout.

Recently Viewed Items

Related Products